Strona Badania kliniczne Nct

Clinical Trial Results:
A long term, double-blind, randomized, parallel-group, carbidopa/levodopa controlled, multi-center study to evaluate the effect of Stalevo® in patients with Parkinson’s disease requiring initiation of levodopa therapy.

Summary
EudraCT number
2004-000185-12
Trial protocol
FI   SE   AT   GB   IT  
Global completion date
11 Nov 2008

Paediatric regulatory details
Is the trial part of an agreed EMA paediatric investigation plan?
No
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006?
No
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006?
No

Results information
Results version number
v1(current)
This version publication date
31 Mar 2016
First version publication date
31 Mar 2016
Other versions
Summary report(s)
CELC200A2401_CT_gov_results
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03 for further information.
3
Subskrybuj